Skip to content
KI: Neue Arbeitsgruppe AMBIOM

New AMBIOM Group: Jianxu Chen Wants to Develop „Eyes & Brains“

Dortmund, 20th September 2021

Medical imaging generates enormous amounts of data that can neither be managed efficiently nor evaluated thoroughly without artificial intelligence (AI). Therefore, ISAS has expanded its Biospectroscopy department (headed by Prof Dr Matthias Gunzer) with a new working group. The junior research group AMBIOM - Analysis of Microscopic BIOMedical Images, which is funded by the Federal Ministry of Education and Research, aims to enable a high analytical throughput of microscope images. Led by Dr Jianxu Chen, a renowned expert in biomedical image analysis and deep learning, the working group plans to develop algorithms and methods (open source) by 2026 that will allow countless image data worldwide to be analysed automatically, quickly and economically. "My passion is to build ‘eyes and brains’ for computers to understand image data in medical or biological studies", says Chen. In the future, for example, the work at AMBIOM should allow broad-based new studies on the development of diseases and their consequences at the level of entire organs and organ systems. Furthermore, the AI analysis methods developed at ISAS will support doctors in making diagnostic and therapeutic decisions.

In his research, Chen has focused on developing scalable AI-based biomedical image analysis algorithms, especially for large 3D microscopy image data. Before joining ISAS, the 33-year-old worked for four years at the Allen Institute for Cell Science in Seattle. He recently moved to Dortmund with his family of four for his new job.

Dr. Jianxu Chen hat seine Forschungsarbeit am ISAS aufgenommen.

Dr Jianxu Chen has started his research at ISAS.

© ISAS

About ISAS

The Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. develops efficient and cost-effective analytical methods for health research. Thus, it contributes to the improvement of the prevention, early diagnosis and therapy of diseases. Overall, the institute strives to advance precision medicine by combining knowledge from different fields such as chemistry, biology, pharmacology, physics and computer science. The institute works closely with universities in Germany and abroad, for instance through joint appointments. It also cooperates with national and international partners from science and industry. ISAS was founded in 1952 and has around 200 employees from 20 nations.

Downloads

Share

Further press releases

13th July 2026

Fabry Disease: a Molecular Map of Lipids in Tissue

A new technique developed at ISAS combines Raman microscopy and mass spectrometry imaging, and it demonstrates that, for the first time, the spatial distribution of lipids can be visualised at cellular and subcellular levels – including further essential information. The new analytical method holds high potential for the diagnosis and treatment of conditions such as Fabry disease, in which molecules undergo local changes within the tissue.

2nd July 2026

Biomedical Image Analysis with AI

Dr Jianxu Chen is taking up a professorship in AI for Biomedical Analysis at the University of Duisburg-Essen. With his research group at ISAS, he is developing AI methods that can be used to comprehensively analyse enormous quantities of complex microscopy images.

Portrait von Dr. Jianxu Chen.
29th June 2026

It's What's Inside That Counts: Neutrophils Form Distinct Subtypes

Neutrophils can be divided into two distinct subgroups with completely different functions. The surface protein CD177 plays a decisive role in this. For the first time, researchers from the Faculty of Medicine at the University of Duisburg-Essen and ISAS have been able to demonstrate, using a new integrated proteomics and lipidomics analysis, that the molecular signatures in CD177-defined neutrophils differ significantly from one another. The presence of this surface protein has implications for disease progression, for example in head and neck tumours.

CD177 negative Neutrophile.
26th November 2025

New Drug Candidates for the Treatment of Heart Failure

Researchers from North Rhine-Westphalia are working on a new therapeutic approach for the treatment of heart failure as part of the recently launched HI-FIVE project. They are developing active substances that specifically inhibit an important enzyme with the aim of closing gaps in the care of patients with heart failure.

26th September 2025

Microbiome Research: EU Network METAMIC 3 Is Looking for Doctoral Candidates

In the new EU network METAMIC 3, young scientists will be researching the role of microbiomes in the context of ‘One Health’ for their dissertations. Metaproteomics methods will be applied in this research. Furthermore, stays at various European institutions are part of the doctoral programme. The doctoral positions are now open for applications.

Prof. Dr. Robert Heyer is Head of the research group Multidimensional Omics Data Analysis at ISAS and coordinator of the network.
7th February 2025

The Less the Better

If neutrophil granulocytes migrate into injured tissue, for example into the brain after a stroke, they can promote chronic inflammation and cause long-term damage. In order to analyze the functional dynamics of these immune cells, millions of them are needed. A group of researchers recently developed a method that enables mass spectrometric analysis with just 1,000 neutrophils.

Susmita Ghosh am Massenspektrometer.